*Indiana University School of Medicine, Indianapolis, IN
†Department of Ophthalmology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY
‡Department of Ophthalmology, University of Pavia, Pavia
§IRCCS—Fondazione Bietti, Rome, Italy
∥Eye Clinic of Medical Academy of Lithuanian University of Health Sciences, Kaunas, Lithuania
Disclosure: A.H. receives remuneration from CIPLA, AdOM, and Shire for serving as a consultant. He also holds an ownership interest in AdOM, Nano Retina, and Oxymap. All relationships listed above are pursuant to Indiana University’s policy on outside activities. I.J. reports financial support from Origmed, Santen, and Thea serving as a Consultant/Advisor outside the submitted work. The contribution of the author A.C.V.V. was supported by Fondazione Roma and by the Italian Ministry of Health. The remaining authors declare no conflict of interest.
Reprints: Alon Harris, MS, FARVO, PhD, Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, 1468 Madison Avenue, Annenberg 22-86, New York, NY 10029 (e-mail: [email protected]).
